Jul 20
Current report
8-K
Events of Jul 19
Unregistered sale of equity
RGBP · Regen BioPharma Inc · Documents
$0.00
+0.00 (+0.00%)
At close · Nov 6
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 17, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Without additional funding, there is substantial doubt about the Company's ability to continue as a going concern for the twelve months from the date of these financial statements.”View the 10-Q filed Aug 17, 2026
Market Cap
$335,055
Shares
1.68B
Volume · Nov 6
3.62M
Avg daily vol (3M)
7.96M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →
2022
May 17
Current report
8-K
Events of May 10
Unregistered sale of equity, Other events
Apr 21
Quarterly report
10-Q
FY2022 Q2, ended Mar 31
Quarterly report for FY2022 Q2
Revenue $30.95K
Net loss $67.08M
Mar 18
Current report
8-K
Events of Mar 17
Charter or bylaw amendment, or fiscal year change
Feb 18
Current report
8-K
Other events
Jan 20
Quarterly report
10-Q
FY2022 Q1, ended Dec 31
Quarterly report for FY2022 Q1
Revenue $31.64K
Net income $2.64M
▲ 58.7%
Jan 14
Current report
8-K
Events of Jan 13
New debt or off-balance-sheet obligation
2021
Dec 22
Quarterly report
10-Q/A
FY2021 Q3, ended Jun 30
Quarterly report for FY2021 Q3
Revenue $29.21K
Net loss $7.49M
Dec 22
Current report
8-K
Events of Dec 17
Earlier financial statements no longer reliable
Dec 22
Dec 20
Current report
8-K
Events of Dec 13
Other events
Nov 12
Current report
8-K
Events of Nov 11
Other events
Nov 5
Current report
8-K
Events of Oct 12
Other events
Nov 4
Current report
8-K
Events of Oct 12
Other events
Oct 22
Current report
8-K
Other events
Oct 19
Current report
8-K
Events of Oct 18
Entered into a material agreement
Sep 27
Current report
8-K
Events of Sep 23
Other events
Sep 24
Current report
8-K
Events of Sep 17
Entered into a material agreement, Other events
Sep 16
Current report
8-K
Events of Sep 15
Entered into a material agreement
Aug 31
Current report
8-K/A
Events of Aug 27
Other events
Aug 31
Current report
8-K
Events of Aug 27
Other events
Aug 27
Quarterly report
10-Q
FY2021 Q3, ended Jun 30
Quarterly report for FY2021 Q3
Revenue $1.91M
Net loss $5.61M
Aug 26
Current report
8-K
Events of Aug 17
Other events
Aug 18
Quarterly report
10-Q
FY2021 Q2, ended Mar 31
Quarterly report for FY2021 Q2
Revenue $27.43K
▲ unchanged
Net income $442.18K
Aug 13
Quarterly report
10-Q
FY2021 Q1, ended Dec 31
Quarterly report for FY2021 Q1
Revenue $27.43K
▲ unchanged
Net income $1.67M
▼ 45.9%
Aug 5
Quarterly report
10-Q
FY2020 Q1, ended Dec 31
Quarterly report for FY2020 Q1
Revenue $27.43K
▲ unchanged
Net income $3.08M
▲ 1158.0%
Aug 5
Quarterly report
10-Q
FY2020 Q2, ended Mar 31
Quarterly report for FY2020 Q2
Revenue $27.43K
▲ unchanged
Net loss $4.08M
Aug 5
Quarterly report
10-Q
FY2020 Q3, ended Jun 30
Quarterly report for FY2020 Q3
Revenue $27.43K
▲ unchanged
Net income $3.21M
Aug 4
Annual report
10-K
FY2020, ended Sep 30
Annual report for FY2020
Revenue $110K
▲ unchanged
Net income $3.41M
Jul 14
Current report
8-K
Events of Jul 8
Other events
Jul 13
Current report
8-K
Other events
Jul 2
Current report
8-K
Events of Jun 16
Other events
Jun 30
Current report
8-K
Events of Jun 28
Other events
Jun 28
Current report
8-K
Other events
Jun 21
Annual report
10-K
FY2019, ended Sep 30
Annual report for FY2019
Revenue $110K
▲ 10.0%
Net loss $2.62M
Jun 1
Current report
8-K
Other events
May 13
Current report
8-K
Events of May 12
Other events
May 7
Current report
8-K
Other events
Apr 27
Current report
8-K
Events of Apr 23
Unregistered sale of equity, Change to shareholders' rights
Apr 21
Current report
8-K
Other events
Apr 19
Current report
8-K
Other events
Apr 16
Current report
8-K
Events of Apr 15
Entered into a material agreement
Apr 9
Current report
8-K
Events of Apr 8
Other events
Apr 8
Current report
8-K
Events of Apr 7
Entered into a material agreement
Mar 30
Current report
8-K
Events of Mar 26
Other events
Mar 25
Current report
8-K
Events of Mar 23
Director or officer change, or executive pay
2020
Jan 22
Current report
8-K
Events of Jan 20
Ended a material agreement, Director or officer change, or executive pay
Jan 7
Current report
8-K
Events of Dec 13
Other events
Showing 51–98 of 98 documents